Last reviewed · How we verify
NCT03583788
Effect of Hypnotherapy in Alcohol Use Disorder Compared to Motivational Interviewing.
NA trial testing Hypnotherapy in Alcohol Use Disorder in 31 participants. Completed in 7 February 2018.
1 December 2017
Quick facts
| Lead sponsor | Sykehuset Innlandet HF |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 31 |
| Start date | 1 February 2016 |
| Primary completion | 1 December 2017 |
| Estimated completion | 7 February 2018 |
Drugs / interventions tested
- Hypnotherapy
- Motivational Interviewing
Conditions studied
- Alcohol Use Disorder — all drugs for Alcohol Use Disorder →
Sponsor
Sykehuset Innlandet HF — full company profile →
Who can join
Eligibility, any sex, with Alcohol Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was carried out at an inpatient clinic in Norway. A six- week long treatment programme included intensive group therapy, but also five hours of individual therapy, given as motivational interviewing (MI). Thirty-one patients were randomized either to receive five individual sessions of hypnotherapy instead of MI (N=16) or to be in the control group (N=15). The treatment method for the hypnotherapy group was Erickson's (permissive) hypnosis. At baseline all the participants were diagnosed using a psychiatric interview and filled in the Alcohol Use Identification Test (AUDIT), Time-line-follow-back (TLFB) for alcohol use, Hopkins Symptoms Check List (HSCL-25) for monitoring mental distress and Traumatic Life Events Questionnaire. AUDIT, TLFB and HSCL-25 were re-administered at follow-up after one year.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03583788
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hypnotherapy
Trials testing the same drug.
- NCT06846359 — Treatment of Upper Gastrointestinal Symptoms Using Hypnotherapy Sessions · NA · recruiting
- NCT05572606 — Treatment of Symptomatic Bloating Using a Novel Hypnotherapy Protocol · NA · completed
- NCT04899492 — Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Beh · NA · terminated
- NCT04234737 — Efficacy of Hypnotherapy in Children With Dental Anxiety · NA · completed
- NCT03884270 — Functional Dyspepsia Hypnosis · NA · completed
Other recruiting trials for Alcohol Use Disorder
Currently open trials in the same condition.
- NCT06860607 — Environment and Alcohol: A Pilot Study · Phase 1 · recruiting
- NCT07325266 — Human Laboratory Study of Apremilast for Alcohol Use Disorder · Phase 2 · recruiting
- NCT07046819 — Tirzepatide in MetALD · Phase 2 · recruiting
- NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
- NCT07056894 — Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis · NA · recruiting
Other Sykehuset Innlandet HF trials
Trials by the same sponsor.
- NCT06901128 — The Covideo Study - a Trial of Cognitive Therapy for Social Anxiety Disorder in Youth, Comparing Screen to Office Delive · NA · recruiting
- NCT06790186 — Improving Real-world Function for Persons with Schizophrenia: a Single-case Experimental Design · NA · not yet recruiting
- NCT06403423 — Screening for Aortic Aneurysms in Inland Norway · enrolling by invitation
- NCT05874791 — Executive Control Training for Adolescents With ADHD: A Randomized Controlled Effectiveness Trial · NA · active not recruiting
- NCT07375615 — Continous Glucose Monitoring in Neonates at Risk of Hypoglycaemia- a Feasibility Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03583788 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sykehuset Innlandet HF
- Last refreshed: 11 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03583788.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing